SCANOGEN INC.

Medtech · Private

Automated instrument and assay for rapid detection of yeast bloodstream infections directly in whole blood using Single Molecule Scanning (SMOLT) technology

scanogen.com →
Grants
$18M
25 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
18
10 granted · 8 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Twist-Sensor: Novel microarrays for multiplex detection of drug resistance$299,820
Federal grantDepartment of Health and Human Services · Phase I · Novel microarrays for DNA genotyping in the presence of excess background DNA$350,000
Federal grantDepartment of Health and Human Services · Phase I · Novel Circular Supercoiling Biosensors for MicroRNA Detection$289,322
Federal grantDepartment of Health and Human Services · Phase I · Novel Circular Supercoiling Biosensors for MicroRNA Detection$289,322
Federal grantDepartment of Health and Human Services · Phase I · Rapid Molecular Detection of Tuberculosis without PCR amplification$224,890
Federal grantDepartment of Health and Human Services · Phase I · Bloodstream infection detection directly on whole blood$224,996
Federal grantDepartment of Health and Human Services · Phase II · Rapid Molecular Detection of Tuberculosis without PCR amplification$998,383
Federal grantDepartment of Health and Human Services · Phase I · Research and screening platform for Alzheimer’s and other chronic diseases$299,652
Federal grantDepartment of Health and Human Services · Phase I · Research and screening platform for Alzheimer's and other chronic diseases$599,334
Federal grantDepartment of Health and Human Services · Phase II · Rapid Molecular Detection of Tuberculosis without PCR amplification$998,008
Federal grantDepartment of Health and Human Services · Phase I · Research and screening platform for Alzheimer’s and other chronic diseases$299,682
Federal grantDepartment of Health and Human Services · Phase II · Rapid Molecular Detection of Tuberculosis without PCR amplification$999,998
Federal grantDepartment of Health and Human Services · Phase II · Bloodstream infection detection directly on whole blood$1,000,000
Federal grantDepartment of Health and Human Services · Phase II · Bloodstream infection detection directly on whole blood$994,176
Federal grantDepartment of Health and Human Services · Phase II · Bloodstream infection detection directly on whole blood$988,666
Federal grantDepartment of Health and Human Services · Phase II · Culture and amplification-free bacterial sepsis diagnosis$298,601
Federal grantDepartment of Health and Human Services · Phase II · Culture and amplification-free bacterial sepsis diagnosis$999,995
Federal grantDepartment of Health and Human Services · Phase II · Highly Multiplexed Single Molecule Tethering$999,966
Federal grantDepartment of Health and Human Services · Phase II · Culture and amplification-free bacterial sepsis diagnosis$999,898
Federal grantDepartment of Health and Human Services · Phase II · Highly Multiplexed Single Molecule Tethering$999,900
Federal grantDepartment of Health and Human Services · Phase II · Bloodstream infection detection directly on whole blood$1,000,000
Federal grantDepartment of Health and Human Services · Phase II · Culture and amplification-free bacterial sepsis diagnosis$1,000,000
Federal grantDepartment of Health and Human Services · Phase II · Bloodstream infection detection directly on whole blood$1,000,000
Federal grantDepartment of Health and Human Services · Phase II · Highly Multiplexed Single Molecule Tethering$999,828
Federal grantDepartment of Health and Human Services · Phase II · Bloodstream infection detection directly on whole blood$1,000,000
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
736COOLTECH LLC—$1.1M
737MICROMED CARDIOVASCULAR INC—$11M
738ALEO BME INC——
739SCANOGEN INC.——
740SAUREUS, INC.——
741Brockman-Hastings LLC——
742ASTRADX INC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 10 granted of 18

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.